Trials / Completed
CompletedNCT03780179
MMR at 6 Months Trial
Measles-mumps-rubella Vaccine at 6 Months of Age, Immunology, and Childhood Morbidity in a High-income Setting
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 6,540 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 5 Months – 7 Months
- Healthy volunteers
- Not accepted
Summary
Randomised, double-blind clinical trial to test humoral and cellular immunogenicity, and potential in-direct beneficial effect of the MMRvaxpro-vaccine administered at 6 months of age
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MMRvaxpro | MMRvaxpro vaccine |
| BIOLOGICAL | Placebo | Placebo |
Timeline
- Start date
- 2019-04-15
- Primary completion
- 2022-01-07
- Completion
- 2022-01-07
- First posted
- 2018-12-19
- Last updated
- 2022-01-13
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03780179. Inclusion in this directory is not an endorsement.